177 related articles for article (PubMed ID: 8099951)
1. Reduction of dopamine synthesis inhibition by dopamine autoreceptor activation in striatal synaptosomes with in vivo reserpine administration.
Tissari AH; Lillgäls MS
J Neurochem; 1993 Jul; 61(1):231-8. PubMed ID: 8099951
[TBL] [Abstract][Full Text] [Related]
2. Synaptosomal dopamine autoreceptors: sensitivity changes after in vitro and in vivo treatments.
Tissari AH
Pharmacol Res Commun; 1988 Nov; 20(11):1001-11. PubMed ID: 2853876
[TBL] [Abstract][Full Text] [Related]
3. Increase of dopamine synthesis in synaptosomes from rats treated with neuroleptics or reserpine.
Tissari AH
Med Biol; 1982 Feb; 60(1):38-41. PubMed ID: 6121960
[TBL] [Abstract][Full Text] [Related]
4. Striatal synaptosomal dopamine synthesis: evidence against direct regulation by an autoreceptor mechanism.
Compton DR; Johnson KM
Eur J Pharmacol; 1985 Apr; 110(2):157-62. PubMed ID: 2859213
[TBL] [Abstract][Full Text] [Related]
5. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
el Mestikawy S; Glowinski J; Hamon M
J Neurochem; 1986 Jan; 46(1):12-22. PubMed ID: 2866232
[TBL] [Abstract][Full Text] [Related]
6. Dopamine synthesis in synaptosomes: relation of autoreceptor functioning to pH, membrane depolarization, and intrasynaptosomal dopamine content.
Saller CF; Salama AI
J Neurochem; 1984 Sep; 43(3):675-88. PubMed ID: 6747629
[TBL] [Abstract][Full Text] [Related]
7. Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function?
Fowler CJ; Thorell G; Andersson M; Magnusson O
Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):12-9. PubMed ID: 2866447
[TBL] [Abstract][Full Text] [Related]
8. Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes.
Onali P; Olianas MC; Bunse B
Brain Res; 1988 Jul; 456(2):302-9. PubMed ID: 2905190
[TBL] [Abstract][Full Text] [Related]
9. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
[TBL] [Abstract][Full Text] [Related]
10. Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions.
Saller CF; Salama AI
Eur J Pharmacol; 1986 Feb; 121(2):181-8. PubMed ID: 3699091
[TBL] [Abstract][Full Text] [Related]
11. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
Hoffmann IS; Talmaciu RK; Cubeddu LX
J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
[TBL] [Abstract][Full Text] [Related]
12. Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors.
Yi SJ; Johnson KM
Pharmacol Biochem Behav; 1990 Jul; 36(3):457-61. PubMed ID: 1974064
[TBL] [Abstract][Full Text] [Related]
13. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
Suarez-Roca H; Lovenberg T; Cubeddu LX
J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of dopamine synthesis in striatal synaptosomes by lisuride: stereospecific reversal by (-)-sulpiride.
Tissari AH; Atzori L; Galdieri MT
Naunyn Schmiedebergs Arch Pharmacol; 1983 Feb; 322(1):89-91. PubMed ID: 6843693
[TBL] [Abstract][Full Text] [Related]
15. Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.
Strait KA; Kuczenski R
Mol Pharmacol; 1986 Jun; 29(6):561-9. PubMed ID: 2872588
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of reserpine and tetrabenazine on rat striatal synaptosomal dopamine biosynthesis and synaptosomal dopamine pools.
Kuczenski R
J Pharmacol Exp Ther; 1977 May; 201(2):357-67. PubMed ID: 870679
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the Ca++-evoked release of [3H]dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists.
Bowyer JF; Weiner N
J Pharmacol Exp Ther; 1987 Apr; 241(1):27-33. PubMed ID: 3572788
[TBL] [Abstract][Full Text] [Related]
18. The accumulation of dopamine into striatal synaptosomes, and its inhibition: comparison of crude, partially purified and purified synaptosomal preparations.
Tuomisto J; Tuomisto L
Med Biol; 1979 Aug; 57(4):238-45. PubMed ID: 513880
[No Abstract] [Full Text] [Related]
19. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
20. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
